Topical phenylbutyrate antagonizes NF-κB signaling and resolves corneal inflammation

Chronic inflammation of the immune privileged cornea originating from viral or nonviral conditions results in significant vision loss. Topical corticosteroids are the common treatments for corneal inflammation, but the drugs cause serious and potentially blinding side effects in the long term. There...

Descripción completa

Detalles Bibliográficos
Autores principales: Koganti, Raghuram, Yadavalli, Tejabhiram, Sutar, Yogesh, Mallick, Sudipta, Date, Abhijit, Shukla, Deepak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758524/
https://www.ncbi.nlm.nih.gov/pubmed/36536680
http://dx.doi.org/10.1016/j.isci.2022.105682

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9758524/
https://www.ncbi.nlm.nih.gov/pubmed/36536680
http://dx.doi.org/10.1016/j.isci.2022.105682

Ejemplares similares